- Home
- MOVE vs RDHL Comparison
MOVE vs RDHL Comparison
Compare MOVE & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOVE
- RDHL
- Stock Information
- Founded
- MOVE 2018
- RDHL 2009
- Country
- MOVE United States
- RDHL Israel
- Employees
- MOVE N/A
- RDHL N/A
- Industry
- MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- MOVE Health Care
- RDHL Health Care
- Exchange
- MOVE Nasdaq
- RDHL Nasdaq
- Market Cap
- MOVE 4.5M
- RDHL 3.9M
- IPO Year
- MOVE 2021
- RDHL N/A
- Fundamental
- Price
- MOVE $0.88
- RDHL $1.45
- Analyst Decision
- MOVE
- RDHL
- Analyst Count
- MOVE 0
- RDHL 0
- Target Price
- MOVE N/A
- RDHL N/A
- AVG Volume (30 Days)
- MOVE 7.2M
- RDHL 92.2K
- Earning Date
- MOVE 09-19-2025
- RDHL 09-05-2025
- Dividend Yield
- MOVE N/A
- RDHL N/A
- EPS Growth
- MOVE N/A
- RDHL N/A
- EPS
- MOVE N/A
- RDHL N/A
- Revenue
- MOVE $1,013,000.00
- RDHL $9,550,000.00
- Revenue This Year
- MOVE $1,460.71
- RDHL $381.91
- Revenue Next Year
- MOVE $96.77
- RDHL N/A
- P/E Ratio
- MOVE N/A
- RDHL N/A
- Revenue Growth
- MOVE N/A
- RDHL 157.62
- 52 Week Low
- MOVE $0.51
- RDHL $1.06
- 52 Week High
- MOVE $6.97
- RDHL $12.50
- Technical
- Relative Strength Index (RSI)
- MOVE 55.71
- RDHL 52.27
- Support Level
- MOVE $0.86
- RDHL $1.22
- Resistance Level
- MOVE $1.18
- RDHL $1.49
- Average True Range (ATR)
- MOVE 0.16
- RDHL 0.08
- MACD
- MOVE 0.04
- RDHL 0.03
- Stochastic Oscillator
- MOVE 43.21
- RDHL 85.19
About MOVE Movano Inc.
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.